Latest Competition News

Elanor Commercial Property Fund has reaffirmed its FY26 distribution guidance while urging securityholders to reject a takeover offer it deems undervalued and opportunistic.

Atlas Arteria has announced an ordinary dividend of AUD 0.20 per security for the six months ending June 2025, payable in early October. The dividend is fully unfranked, reflecting the company’s international income streams.

The Fair Competition Commission of Tanzania has approved Shenghe Resources’ acquisition of Peak Rare Earths, clearing a major regulatory hurdle for the deal. The scheme now awaits Australian court approval and independent expert endorsement.

Peak Rare Earths has postponed its critical court hearing for Shenghe Resources' acquisition scheme due to a delay in Tanzanian regulatory approval, pushing the decision to 19 September 2025.

Generation Development Group Limited has updated its Dividend Reinvestment Plan price to AUD 6.70 per share, accompanying a fully franked ordinary dividend of 1 cent per share for the half-year ending June 2025.

Garda Property Group has announced a quarterly distribution of AUD 0.02 per security for the period ending September 30, 2025, incorporating a notable non-cash capital gain component from a recent asset sale.

My Foodie Box Limited has raised $500,000 through unsecured promissory notes to support its transformation into Tarrina Resources and relisting on the ASX as a resource exploration company.

Resimac Group has successfully settled a A$1 billion non-conforming residential mortgage backed securities transaction, marking its second such bond issuance this year. The deal attracted strong domestic and offshore investor interest, reinforcing Resimac’s diversified funding strategy.

Xamble Group Limited has successfully closed a partially underwritten rights issue, raising approximately A$1.36 million to accelerate its digital marketing platform expansion in Southeast Asia.

Blue Star Helium has decided not to exercise its purchase option on key Colorado helium assets after thorough evaluation, signaling a strategic pivot in its growth approach.

Tempest Minerals has secured regulatory approval to begin Phase I drilling at its Halo prospect within the Yalgoo Project, targeting iron, copper, and gold. A heritage survey with the Badimia People is currently in progress, marking a key step toward unlocking the site's potential.

Neurizon Therapeutics has locked in a significant R&D tax incentive advance covering overseas and domestic development costs for its lead ALS drug candidate NUZ-001, accelerating its clinical progress with a $5.6 million rebate expected in 2025.